• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α7 烟碱型乙酰胆碱受体激动剂 PNU-282987 可减轻炎症和 MPTP 诱导的小鼠黑质多巴胺能神经元丢失。

The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice.

机构信息

Department of Neurology, Philipps-University of Marburg, Baldingerstrasse, Marburg, Germany.

出版信息

J Parkinsons Dis. 2013;3(2):161-72. doi: 10.3233/JPD-120157.

DOI:10.3233/JPD-120157
PMID:23938346
Abstract

BACKGROUND

Parkinson's disease (PD) is associated with neurodegeneration of dopaminergic neurons and an accompanying neuroinflammatory process in the substantia nigra (SN). The cholinergic anti-inflammatory signalling pathway allows the autonomic nervous system to modulate immunologic stimuli and inflammatory processes. A major component of this pathway is the α7 nicotinic acetylcholine receptor (α7 nACh receptor), which is expressed on immune cells such as microglia.

OBJECTIVE

To determine the role of this cholinergic anti-inflammatory signalling pathway, we investigated the effects of the selective α7 nACh agonist PNU-282987 and of the non-competitive nACh antagonist mecamylamine on microglia-induced neuroinflammation and toxin-induced degeneration of dopaminergic neurons in a mouse model of PD.

METHODS

PNU-282987, mecamylamine or placebo administration was started one day before MPTP intoxication and repeated daily until sacrifice after MPTP intoxication. C57Bl/6 mice were injected intraperitoneally four times at 2 h intervals with either 20 mg/kg MPTP-HCl or a corresponding volume of saline. Two or seven days after the end of the MPTP intoxication, the animals were killed and their brains were processed for further analysis.

RESULTS

Treatment with PNU-282987 resulted in an attenuation of neuroinflammation in the MPTP-lesioned SN. Furthermore, PNU-282987 attenuated MPTP-induced dopaminergic cell loss in the SN and reduced striatal dopamine depletion. Unexpectedly, mecamylamine lowered neuroinflammation as well, though it did not show a neuroprotective potential at the nigral level.

CONCLUSIONS

Our results demonstrate the therapeutic potential of the selective α7 nicotinic acetylcholine agonist PNU-282987 in attenuating neuroinflammation and toxin-induced loss of dopaminergic neurons in the acute MPTP mouse model of PD.

摘要

背景

帕金森病(PD)与多巴胺能神经元的神经退行性变以及黑质(SN)中的伴随神经炎症过程有关。胆碱能抗炎信号通路使自主神经系统能够调节免疫刺激和炎症过程。该途径的主要组成部分是α7 烟碱型乙酰胆碱受体(α7 nACh 受体),其在免疫细胞(如小胶质细胞)上表达。

目的

为了确定该胆碱能抗炎信号通路的作用,我们研究了选择性α7 nACh 激动剂 PNU-282987 和非竞争性 nACh 拮抗剂美金刚胺对 PD 小鼠模型中小胶质细胞诱导的神经炎症和毒素诱导的多巴胺能神经元变性的影响。

方法

PNU-282987、美金刚胺或安慰剂给药于 MPTP 中毒前一天开始,每天重复直至 MPTP 中毒后处死。C57Bl/6 小鼠经腹腔注射 4 次,间隔 2 小时,每次 20 mg/kg MPTP-HCl 或相应体积的生理盐水。MPTP 中毒结束后 2 天或 7 天,处死动物并处理其大脑进行进一步分析。

结果

PNU-282987 治疗可减轻 MPTP 损伤 SN 中的神经炎症。此外,PNU-282987 减轻了 MPTP 诱导的 SN 中多巴胺能神经元丢失,并减少了纹状体多巴胺耗竭。出乎意料的是,美金刚胺也降低了神经炎症,尽管它在黑质水平没有表现出神经保护潜力。

结论

我们的研究结果表明,选择性α7 烟碱乙酰胆碱激动剂 PNU-282987 具有治疗潜力,可减轻急性 MPTP 小鼠 PD 模型中的神经炎症和毒素诱导的多巴胺能神经元丢失。

相似文献

1
The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice.α7 烟碱型乙酰胆碱受体激动剂 PNU-282987 可减轻炎症和 MPTP 诱导的小鼠黑质多巴胺能神经元丢失。
J Parkinsons Dis. 2013;3(2):161-72. doi: 10.3233/JPD-120157.
2
CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease.CNI-1493 可减轻急性 MPTP 帕金森病小鼠模型中的神经炎症和多巴胺能神经退行性变。
Neurodegener Dis. 2013;12(2):103-10. doi: 10.1159/000342714. Epub 2012 Nov 7.
3
Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.血管紧张素转换酶抑制剂培哚普利对MPTP处理小鼠中间神经元的影响。
Eur Neuropsychopharmacol. 2005 Jan;15(1):57-67. doi: 10.1016/j.euroneuro.2004.05.007.
4
CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.CX3CR1基因敲除对帕金森病小鼠多巴胺能神经元变性的影响因神经毒素和给药途径而异。
Neurotox Res. 2016 Apr;29(3):364-80. doi: 10.1007/s12640-015-9557-5. Epub 2015 Sep 24.
5
Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease.多巴胺受体D3的药理拮抗作用可减轻帕金森病小鼠模型中的神经退行性变和运动障碍。
Neuropharmacology. 2017 Feb;113(Pt A):110-123. doi: 10.1016/j.neuropharm.2016.09.028. Epub 2016 Sep 28.
6
Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.在帕金森病的临床前模型中,一种具有口服活性的夹竹桃麻素衍生物的抗炎和神经保护作用。
J Neuroinflammation. 2012 Oct 23;9:241. doi: 10.1186/1742-2094-9-241.
7
Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?NAC 治疗和身体活动对亚慢性帕金森病神经炎症的影响;身体活动是否必不可少?
J Neuroinflammation. 2018 Nov 26;15(1):328. doi: 10.1186/s12974-018-1357-4.
8
The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.5α-还原酶抑制剂度他雄胺而非非那雄胺可保护帕金森病MPTP小鼠模型中的多巴胺能神经元。
Neuropharmacology. 2015 Oct;97:86-94. doi: 10.1016/j.neuropharm.2015.05.015. Epub 2015 May 23.
9
Cholinergic and Dopaminergic Alterations in Nigrostriatal Neurons Are Involved in Environmental Enrichment Motor Protection in a Mouse Model of Parkinson's Disease.黑质纹状体神经元中的胆碱能和多巴胺能改变参与帕金森病小鼠模型中环境富集的运动保护作用。
J Mol Neurosci. 2016 Dec;60(4):453-464. doi: 10.1007/s12031-016-0831-7. Epub 2016 Sep 22.
10
Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.在帕金森病的MPTP小鼠模型中,全身给药的神经调节蛋白-1β1通过ErbB4受体酪氨酸激酶挽救黑质多巴胺能神经元。
J Neurochem. 2015 May;133(4):590-7. doi: 10.1111/jnc.13026. Epub 2015 Jan 26.

引用本文的文献

1
Targeting Neuronal Alpha7 Nicotinic Acetylcholine Receptor Upregulation in Age-Related Neurological Disorders.靶向年龄相关性神经疾病中神经元α7烟碱型乙酰胆碱受体上调
Cell Mol Neurobiol. 2025 Jul 16;45(1):70. doi: 10.1007/s10571-025-01586-6.
2
The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson's Disease.α7-烟碱型乙酰胆碱受体在帕金森病病理生理学及治疗中的作用
Int J Mol Sci. 2025 Mar 30;26(7):3210. doi: 10.3390/ijms26073210.
3
Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases.
烟碱型乙酰胆碱受体功能障碍与成瘾及某些神经退行性和神经精神疾病。
Cells. 2023 Aug 11;12(16):2051. doi: 10.3390/cells12162051.
4
Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders.α7烟碱型乙酰胆碱受体在脑部疾病中的生理功能及治疗应用
Pharmaceutics. 2022 Dec 22;15(1):31. doi: 10.3390/pharmaceutics15010031.
5
Role of the Cholinergic Anti-Inflammatory Reflex in Central Nervous System Diseases.胆碱能抗炎反射在中枢神经系统疾病中的作用。
Int J Mol Sci. 2021 Dec 14;22(24):13427. doi: 10.3390/ijms222413427.
6
Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3.通过 α7 烟碱型乙酰胆碱受体及其伴侣蛋白 RIC-3 调节神经炎症
Molecules. 2021 Oct 11;26(20):6139. doi: 10.3390/molecules26206139.
7
Electroacupuncture Pretreatment Ameliorates Anesthesia and Surgery-Induced Cognitive Dysfunction via Activation of an α7-nAChR Signal in Aged Rats.电针预处理通过激活老年大鼠的α7烟碱型乙酰胆碱受体信号改善麻醉和手术诱导的认知功能障碍。
Neuropsychiatr Dis Treat. 2021 Aug 10;17:2599-2611. doi: 10.2147/NDT.S322047. eCollection 2021.
8
Protective Effect of the α7 Nicotinic Receptor Agonist PNU-282987 on Dopaminergic Neurons Against 6-Hydroxydopamine, Regulating Anti-neuroinflammatory and the Immune Balance Pathways in Rat.α7烟碱受体激动剂PNU-282987对多巴胺能神经元抗6-羟基多巴胺的保护作用,调节大鼠的抗神经炎症和免疫平衡途径
Front Aging Neurosci. 2021 Jan 25;12:606927. doi: 10.3389/fnagi.2020.606927. eCollection 2020.
9
Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson's disease.烟碱型α7和σ1受体激动剂联合疗法在帕金森病大鼠模型中的神经保护和抗炎作用
Neural Regen Res. 2021 Jun;16(6):1099-1104. doi: 10.4103/1673-5374.300451.
10
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.烟碱型乙酰胆碱受体药物在运动障碍中的治疗潜力。
Nicotine Tob Res. 2019 Feb 18;21(3):357-369. doi: 10.1093/ntr/nty063.